NEW YORK (GenomeWeb News) – Next-generation sequencing-based cancer testing firm OncoDNA has been chosen by the National Blood and Cancer Center in Saudi Arabia as a preferred supplier of molecular diagnostic tests to parts of the Middle East.

Under the terms of the agreement, OncoDNA will make available its OncoDEEP DX and OncoDEEP Clinical cancer panels to Gulf Cooperation Council countries, comprising Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.